Correction to: British Journal of Cancer (2015) 113, 1020–1026. doi:10.1038/bjc.2015.306
It has been brought to our attention that there is an error in Figure 3 of the above paper published in advance online on 1 September 2015. The original label above the figure reads as ‘ARK-2 E93Q’. It should be corrected to ‘ARK-2 R93Q’.
Change history
01 December 2015
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2015.306
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Black, J., Lopez, S., Cocco, E. et al. Erratum: PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas. Br J Cancer 113, 1641 (2015). https://doi.org/10.1038/bjc.2015.388
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2015.388
